Menu

Blog

Mar 14, 2024

Novel oral hormone therapy shows promising results for prostate cancer treatment with radiation therapy

Posted by in category: biotech/medical

A study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. This work is published in JAMA Oncology.

Comments are closed.